The National Cancer Institute (NCI) is offering this grant to support innovative, early-stage development of technologies in biospecimen science, specifically addressing pre-analytical variations in cancer-relevant biospecimen collection, processing, and storage. This grant is for developing tools, devices, and methods to interrogate and maximize biospecimen quality and utility for downstream molecular analyses. These technologies will assess sample quality, preserve integrity, and establish verification criteria. Ultimately, they are expected to accelerate and enhance cancer research across biology, prevention, diagnosis, and treatment by reducing quality-affecting variations. All projects require quantitative milestones.
Opportunity ID: 135255
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-12-004 |
| Funding Opportunity Title: | Innovative and Early-Stage Development of Emerging Technologies in Biospecimen Science (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 21, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 18, 2012 |
| Current Closing Date for Applications: | Sep 18, 2012 |
| Archive Date: | Oct 19, 2012 |
| Estimated Total Program Funding: | $800,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments For profit organizations other than small businesses Small businesses Private institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education State governments Special district governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), solicits grant applications proposing technically innovative feasibility studies focused on early stage development of technologies that address issues related to pre-analytical variations in the collection, processing, handling, and storage of cancer-relevant biospecimens or their derivatives. The overall goal is to develop technologies capable of interrogating and/or maximizing the quality and utility of biospecimens or samples derived from those biospecimens for downstream molecular analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to potentially accelerate and/or enhance research in cancer biology, prevention, diagnosis, treatment, epidemiology, and cancer health disparities, by reducing pre-analytical variations that affect biospecimen and/or sample quality. All projects must include quantitative milestones (i.e. technical metrics that determine whether the specific aims have been accomplished). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-004.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B2 | ADOBE-FORMS-B2 | PKG00089374 | Jan 23, 2012 | Sep 18, 2012 | View |
Package 1
Mandatory forms
135255 RR_SF424_1_2-1.2.pdf
135255 PerformanceSite_1_4-1.4.pdf
135255 RR_OtherProjectInfo_1_3-1.3.pdf
135255 RR_KeyPersonExpanded_1_2-1.2.pdf
135255 PHS398_CoverPageSupplement_1_4-1.4.pdf
135255 PHS398_ResearchPlan_1_3-1.3.pdf
135255 PHS398_Checklist_1_3-1.3.pdf
Optional forms
135255 RR_SubawardBudget30-1.2.pdf
135255 PHS398_ModularBudget_1_2-1.2.pdf
135255 RR_Budget-1.1.pdf
135255 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
